Order Article Reprints

Kubeš J, Sláviková S, Vítek P, Haas A, Ondrová B, Dedečková K, Andrlík M, Domanský M, Jiránková K, Schlencová V, et al. 5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis. Cancers. 2023; 15(18):4571. https://doi.org/10.3390/cancers15184571

Kubeš, Jiri, Silvia Sláviková, Pavel Vítek, Alexandra Haas, Barbora Ondrová, Kateřina Dedečková, Michal Andrlík, Martin Domanský, Kateřina Jiránková, Veronika Schlencová, and et al. 2023. "5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis" Cancers 15, no. 18: 4571. https://doi.org/10.3390/cancers15184571

Kubeš, J., Sláviková, S., Vítek, P., Haas, A., Ondrová, B., Dedečková, K., Andrlík, M., Domanský, M., Jiránková, K., Schlencová, V., Harazimová, A., Turková, B., Doležal, T., Al-Hamami, S. F. A., & Vondráček, V. (2023). 5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis. Cancers, 15(18), 4571. https://doi.org/10.3390/cancers15184571